Logo of Dorsavi (ASX:DVL)Latest Dorsavi (ASX:DVL) News

Page 4
Page 4 of 6

Market Wrap - Week 12 (16 Mar -> 20 Mar) 2026

A brutal split opened up in small caps: a few stocks surged on hard approvals and funding, while many resource names slid even after announcing big numbers. The week’s tape looked simple: investors paid for certainty and sold anything that still needs time, permits, or more cash.
Logan Eniac
21 Mar 2026

dorsaVi Leverages Real-Time AI to Win Elite Sport and European Clinical Deals

dorsaVi has secured significant commercial and clinical milestones with new elite sports and European clinical partnerships, showcasing its advanced real-time AI sensor technology.
Victor Sage
17 Mar 2026

Technology Wrap - Week 11 (9 Mar -> 13 Mar) 2026

Tech microcaps swung hard as funding news, contract wins and disclosure issues collided. The biggest falls came where investors saw either forced selling or more cash needs ahead.
Logan Eniac
14 Mar 2026

dorsaVi Advances RRAM Testing for Next-Gen AI Memory at 22-nm Node

dorsaVi has initiated early-stage evaluation of resistive RAM (RRAM) test chips, marking a key step toward an advanced 22-nm memory platform designed to meet rising AI-driven demands in edge computing.
Sophie Babbage
13 Mar 2026

Technology Wrap - Week 10 (2 Mar -> 6 Mar) 2026

A single trading halt lit a fire under one small-cap, while a string of fundraisings reminded investors how often growth still needs fresh cash. Elsewhere, “AI-first” is splitting into two camps: products that ship now, and stories that still need proof.
Logan Eniac
7 Mar 2026

dorsaVi Assembles Elite Advisory Board to Drive Edge AI Robotics Revolution

dorsaVi has formed a world-class Technical Advisory Board to accelerate its pioneering ‘Intelligence at the Ultra Edge’ strategy, integrating advanced memory and neuromorphic computing into robotics and healthcare devices.
Sophie Babbage
5 Mar 2026

DorsaVi’s Losses Surge to $3.6M as Revenue Slips and Expenses Soar

DorsaVi Limited reported a steep increase in its half-year loss to $3.6 million, driven by declining revenues and a sharp rise in operating costs, despite raising over $5 million in fresh capital.
Victor Sage
26 Feb 2026

Technology Wrap - Week 5 (26 Jan -> 30 Jan) 2026

A handful of small caps ripped higher, but plenty still slipped even after good news. This week’s biggest moves came from a platform partnership win, a reinstated stock, and a cash settlement that removed a long-running dispute.
Logan Eniac
31 Jan 2026

dorsaVi Accelerates US Expansion and Advances Cutting-Edge AI Memory Tech

dorsaVi reports strong US commercial growth with over 100 new physical therapy sites and a 50% rise in cash receipts, alongside a strategic leadership change and breakthrough neuromorphic technology acquisition.
Sophie Babbage
29 Jan 2026

dorsaVi Advances RRAM to 22-nm Node in Robotics and Wearables Push

dorsaVi has launched a multi-year collaboration with leading Asian research institutes to develop its proprietary RRAM technology at the 22-nanometer node, targeting AI-driven robotics and wearable applications.
Sophie Babbage
28 Jan 2026

DorsaVi Advances RRAM Tech for Next-Gen Edge AI at 22nm Node

DorsaVi reports significant progress in its resistive RAM (RRAM) development, optimizing memory technology for integration with neuromorphic computing at the 22nm technology node. This advancement positions the company to deliver energy-efficient edge-AI solutions for wearables, robotics, and industrial safety.
Sophie Babbage
5 Dec 2025

dorsaVi Secures Exclusive Neuromorphic IP to Revolutionize Wearables and Robotics

dorsaVi Limited has acquired a cutting-edge neuromorphic processing-in-memory technology portfolio, positioning itself at the forefront of next-generation wearable and robotics intelligence. This strategic move, coupled with leadership changes, signals a new era for the company’s adaptive biosensor and robotics platforms.
Sophie Babbage
12 Nov 2025